Brookline Capital Acquisition Corp.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a BCAC research report →
Price Chart
About the company
Brookline Capital Acquisition Corp. , established in New York in 2020, currently maintains no active business operations. Instead, its primary objective is to complete a strategic business combination, such as a merger, asset acquisition, or stock purchase, with an existing company.
- CEO
- James Jiayuan Tong
- IPO
- 2021
- HQ
- DE, US
Get TickerSpark's AI analysis on BCAC
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $559.61M
- P/E
- -462.53
- PEG
- 0.40
- P/S
- 0.00
- P/B
- 35203809.90
- EV/EBITDA
- -1156.08
- Div Yield
- 0.00%
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- -3022.17%
- ROIC
- -782.30%
Latest fiscal year · YoY change
- Revenue
- $0+0.0%
- Gross Profit
- $0+0.0%
- Op Income
- $-603,185
- Net Income
- $-364,939+0.0%
- EPS
- $-0.05+0.0%
- OCF Growth
- +0.0%
- FCF Growth
- +0.0%
- Beta
- 0.01
- RSI (14)
- 94
No earnings-call transcripts are available for BCAC yet.
- Free Float
- 89.9%
- Shares Outstanding
- 24.64M
- Float Shares
- 22.16M
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Feb 11, 21 | GLAZER CAPITAL, LLC | sell | 400,000 |
| Jan 29, 21 | GLAZER CAPITAL, LLC | other | 0 |
| Jan 28, 21 | Serafini Tito | other | 0 |
| May 25, 18 | Wu Peidong | other | 0 |
| Sep 28, 17 | Bu Fan | other | 0 |
| Jun 28, 17 | Xu Peixin | buy | 39,375 |
| Jun 28, 17 | Xu Peixin | buy | 39,375 |
| Jun 28, 17 | Xu Peixin | buy | 39,375 |
| Jun 28, 17 | Xu Peixin | buy | 19,688 |
| Jun 28, 17 | Jiang Fengyun | buy | 39,375 |
A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.
Our BCAC coverage
Recent articles, reports, and earnings notes.
No research on BCAC yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate BCAC report →